European Journal of Clinical Microbiology

, Volume 3, Issue 4, pp 367–367 | Cite as

Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens

  • M. Diez-Enciso
  • G. Mas-Jimenez
  • A. Velasco-Cerrudo
  • A. Gutierrez-Altes
Correspondence

References

  1. 1.
    King, A., Warren, C., Shannon, K., Phillips, I.: In vitro antibacterial activity of norfloxacin (MK-0366). Antimicrobial Agents and Chemotherapy 1982, 21: 604–607.Google Scholar
  2. 2.
    Wise, R., Andrews, J. M., Edward, L. J.: In vitro activity of Bay o 9867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559–564.Google Scholar
  3. 3.
    Bauernfeind, A., Petermüller, C.: In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. European Journal of Clinical Microbiology 1983, 2: 111–115.Google Scholar
  4. 4.
    Shungu, D. L., Weinberg, E., Gadebusch, H. H.: In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens. Antimicrobial Agents and Chemotherapy 1983, 23: 86–90.Google Scholar
  5. 5.
    Ericsson, H. M., Sherris, J. C.: Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathologica et Microbiologica Scandinavica (B) 1971, Supplement 217: 1–90.Google Scholar

Copyright information

© Vieweg Publishing 1984

Authors and Affiliations

  • M. Diez-Enciso
    • 1
  • G. Mas-Jimenez
    • 1
  • A. Velasco-Cerrudo
    • 1
  • A. Gutierrez-Altes
    • 1
  1. 1.Servicio de MicrobiologiaC. S. “La Paz”Madrid-34Spain

Personalised recommendations